Yubo International Biotech Ltd (YBGJ) SEC Filing 8-K Material Event for the period ending Tuesday, April 13, 2021

Magna Lab Inc

CIK: 895464 Ticker: YBGJ

View differences made from one to another to evaluate Magna Lab Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Magna Lab Inc.


Assess how Magna Lab Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Magna Lab Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2021 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Material Contracts, Statements, Certifications & more

Magna Lab Inc provided additional information to their SEC Filing as exhibits

Ticker: YBGJ
CIK: 895464
Form Type: 8-K Corporate News
Accession Number: 0001640334-21-000872
Submitted to the SEC: Tue Apr 13 2021 4:05:51 PM EST
Accepted by the SEC: Tue Apr 13 2021
Period: Tuesday, April 13, 2021
Industry: Electromedical And Electrotherapeutic Apparatus
  1. Bylaw Change
  2. Financial Exhibit

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: